Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

1.33
Delayed Data
As of Mar 29
 -0.0228 / -1.69%
Today’s Change
1.27
Today|||52-Week Range
2.67
-9.22%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close1.35
Today’s open1.35
Day’s range1.27 - 1.36
Volume27,674
Average volume (3 months)31,994
Market cap$26.2M
Dividend yield--
Data as of 3:10pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)+17.60%
Earnings growth (this year)-8.87%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.97

Competitors

 Today’s
change
Today’s
% change
EYEGEyeGate Pharmaceutic...-0.05-2.00%
ITUSITUS Corp-0.13-3.91%
VICLVical Inc+0.11+5.00%
AVIRAviragen Therapeutic...+0.04+6.67%
Data as of 3:59pm ET, 03/29/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
James Garner
Chief Financial Officer
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts


Search for Jobs